Spring is just around the corner, and The Aesthetic Society is already experiencing renewed energy and new growth. I wanted to answer some questions about what’s next.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
In this update, Dr. Pfeifer recaps key highlights from The Aesthetic MEET in Austin, shares insights from attending APS Korea, issues an important cybersecurity warning for plastic surgeons, and previews the upcoming Aesthetic Interactive: Facial & Rhinoplasty Symposium in Boca Raton, Florida.